ODLUMIVIE Ceramide ReviCell Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
ODLUMIVIE Ceramide ReviCell Cream
Generic name
CERAMIDE NP
Manufacturer
ODLUMIVIE
Product type
HUMAN OTC DRUG
SPL set ID
435ee48f-1b9e-6d08-e063-6394a90af5b5
SPL ID
435ee333-664b-a427-e063-6294a90a3810
Version
28
Effective date
2025-11-11
Source export date
2026-10-12
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:58:09
Harmonized routes table
Harmonized routes
CUTANEOUS

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

CAUTION For external use only. Avoid direct contact with eyes.If irritation occurs, stop useand consult a doctor ifneeded.Patch test recommended.Do not use if you are allergic to any of the ingredients.Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.